Humans of AI3SD: Dr Martin Immanuel-Bittner
Humans of AI3SD: Dr Martin Immanuel-Bittner
Martin-Immanuel Bittner MD DPhil FRSA is the chief executive officer of Arctoris, the world’s first fully automated drug discovery platform that he co-founded in Oxford in 2016. He graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. Martin has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations.
In this Humans of AI3SD interview he discusses how automation can provide fully reproducible, robust and reliable research data, the rise of FAIR data and why experienced postdocs should not be spending eight hours a day pipetting small amounts of liquids.
AI3SD, Interview
University of Southampton
Pauli, Michelle
ba2e52e9-984d-47c6-b32b-c6ff10db9542
Immanuel-Bittner, Martin
7b20b24b-8df1-43d2-b916-b8ae2baef1d6
Kanza, Samantha
b73bcf34-3ff8-4691-bd09-aa657dcff420
Frey, Jeremy G.
ba60c559-c4af-44f1-87e6-ce69819bf23f
Niranjan, Mahesan
5cbaeea8-7288-4b55-a89c-c43d212ddd4f
2021
Pauli, Michelle
ba2e52e9-984d-47c6-b32b-c6ff10db9542
Immanuel-Bittner, Martin
7b20b24b-8df1-43d2-b916-b8ae2baef1d6
Kanza, Samantha
b73bcf34-3ff8-4691-bd09-aa657dcff420
Frey, Jeremy G.
ba60c559-c4af-44f1-87e6-ce69819bf23f
Niranjan, Mahesan
5cbaeea8-7288-4b55-a89c-c43d212ddd4f
Pauli, Michelle and Immanuel-Bittner, Martin
,
Kanza, Samantha, Frey, Jeremy G. and Niranjan, Mahesan
(eds.)
(2021)
Humans of AI3SD: Dr Martin Immanuel-Bittner
(Humans-of-AI3SD, 10)
University of Southampton
(doi:10.5258/SOTON/P0154).
Record type:
Monograph
(Project Report)
Abstract
Martin-Immanuel Bittner MD DPhil FRSA is the chief executive officer of Arctoris, the world’s first fully automated drug discovery platform that he co-founded in Oxford in 2016. He graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. Martin has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations.
In this Humans of AI3SD interview he discusses how automation can provide fully reproducible, robust and reliable research data, the rise of FAIR data and why experienced postdocs should not be spending eight hours a day pipetting small amounts of liquids.
Text
Humans_of_AI3SD_Interview-10-MIB
- Version of Record
More information
Published date: 2021
Additional Information:
Martin-Immanuel Bittner MD DPhil is the Chief Executive Officer of Arctoris, the world's first fully automated drug discovery platform that he cofounded in 2016. He graduated as a medical doctor from the University of Freiburg in Germany, followed by his DPhil in Oncology as a Rhodes scholar at the University of Oxford. Martin has extensive research experience covering both clinical trials and preclinical drug discovery and is an active member of several leading cancer research organisations, including EACR, AACR, and ESTRO. In recognition of his research achievements, he was elected a member of the Young Academy of the German National Academy of Sciences in 2018.
Keywords:
AI3SD, Interview
Identifiers
Local EPrints ID: 451469
URI: http://eprints.soton.ac.uk/id/eprint/451469
PURE UUID: d99d5629-8314-45e3-bd8e-34def6179dec
Catalogue record
Date deposited: 29 Sep 2021 19:30
Last modified: 17 Mar 2024 03:51
Export record
Altmetrics
Contributors
Author:
Michelle Pauli
Author:
Martin Immanuel-Bittner
Editor:
Mahesan Niranjan
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics